Global Medical Indication Lead - Rheumatology
This job is no longer available
There are still lots of open positions. Let's find the one that's right for you.
About The Position
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases. We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. The purpose of this position is to lead the clinical team for an indication: translating the TPP as set by the Asset Strategy Team into a Clinical Development Plan that answers the relevant questions, safeguarding time, quality and budget, in close collaboration with the other members of this cross functional team, in order to maximize the potential of the Asset for a given indication. This is a hybrid role and will have frequent trips to the Boston office. EST preferred.
